Farmacoriflessioni
Le linee guida della SIP e dell’AAP sull’otite media acuta
GUIDELINES FOR ACUTE OTITIS MEDIA RECOMMENDED BY THE ITALIAN PAEDIATRIC SOCIETY (SIP) AND THE AMERICAN ACADEMY OF PEDIATRICS (AAP)
G. Longo
Marzo 2011 - pagg. 175 -179
Abstract
The debate about acute otitis media (AOM) is endless, like any other subject that greatly
affects the daily routine of the family paediatrician. However, much greater rigour is
needed in the use of antibiotics (to safeguard a heritage that is certainly not infinite), so
our prescription habits must be reassessed. Therefore, the vigilant wait in AOM has become
a possible tested and recommended behaviour that today guidelines have opportunely
fixed. There are no longer excuses or justifications. However, it is true that otitis
with severe otalgia (eversion of the tympanic membrane) must be opportunely and conveniently
treated immediately upon the onset at all ages. A few days of therapy with high
doses of amoxicillina three times a day is the best treatment. The association with
clavulanic acid should mainly be administered to children under 2 years old.
Parole chiave
Classificazione MeSH
Bibliografia
1. Marchisio P, Principi N, Bellussi L (coordinatori).
Otite Media Acuta: dalla diagnosi alla
prevenzione. Linee Guida della Societŕ Italiana
di Pediatria, 2010. http://www.sip.it/documenti/
otite.pdf.
2. Marchetti F. Panizon F. Infezioni delle vie
respiratorie e antibiotico: sě, no, quando? Medico
e Bambino 2010;29:577-84.
3. Klein JO. Is acute otitis media a treatable disease?
N Engl J Med 2011;364:168-9.
4. Tähtinen PA, Laine MK, Huovinen P, et al. A
placebo-controlled trial of antimicrobial treatment
for acute otitis media. N Engl J Med
2011;364:116-26.
5. Hoberman A, Paradise JL, Rockette HE.
Treatment of acute otitis media in children under
2 years of age. N Engl J Med2011;364:105-
15.
6. Rothman R, Owens T, Simel DL. Does this
child have acute otitis media? JAMA 2003;
290:1633-40.
7. McCormick DP, Chandler SM, Chonmaitree
T. Laterality of acute otitis media: different
clinical and microbiologic characteristics.
Pediatr Infect Dis J 2007;26:583-8.
8. AAP - American Academy of Pediatrics and
American Academy of family physicians. Diagnosis
and management of acute otitis media.
Pediatrics 2004;113:1451-65.
9. Marchetti F, Ronfani L, Conti Nibali S, Tamburlini
G, for the Italian Study Group on Acute
Otitis Media. Delayed prescription may reduce
the use of antibiotics for acute otitis media. Arch
Pediatr Adolesc Med 2005;159:679-84.
10. Le Saux N, Gaboury I, Baird M, et al. A randomized,
double-blind, placebo-controllednoninferiority
trail of amoxicillin for clinically diagnose
acute otitis media in children6 months
to 5 years of age. CMAJ 2005;172:335-41.
11. Moro ML, Marchi M, Gagliotti C, Di Mario
S, Resi D, “Progetto Bambini e Antibiotici
[ProBA]” Regional Group. Why do paediatricians
prescribe antibiotics? Results of an Italian
regional project. BMC Pediatr 2009;9:69.
12. Orso D, Pizzul MG, Bassani N, et al. Applicabilitŕ
della strategia della “vigile attesa”
nel trattamento dell’OMA: le attitudini dei pediatri
di famiglia in Friuli Venezia Giulia. Medico
e Bambino pagine elettroniche 2010;13
(10) http://www.medicoebambino.com/?id=
RIC1010_10.html.
13. Glasziou PP, Del Mar CB, Sanders SL,
Hayem M. Antibiotics for acute otitis media in
children. Cochrane Database Syst Rev 2004;
(1):CD000219 (revisione 2009).
14. Koopman L, Hoes AW, Glasziou PP, et al.
Antibiotic therapy to prevent the development
of asymptomatic middle ear effusion in children
with acute otitis media: a meta-analysis of
individual patient data. Arch Otolaryngol
Head Neck Surg 2008;134:128-32.
15. Casey JR, Pichichero ME. Changes in frequency
and pathogens causing acute otitis
media in 1995-2003. Pediatr Infect Dis J 2004;
23:824-8.
16. Block SL, Hedrick J, Harrison CJ, et al.
Community-wide vaccination with the heptavalent
pneumococcal conjugate significantly
alters the microbiology of acute otitis media.
Pediatr Infect Dis J 2004;23:829-33.
17. Wald ER, Mason EO Jr, Bradley JS, et al.;
US Pediatric Multicenter Pneumococcal Surveillance
Group Acute otitis media caused by
Streptococcus pneumoniae in children’s hospitals
between 1994 and 1997. Pediatr Infect Dis
J 2001;20:34-9.
18. Schutzman SA, Petrycki S, Fleisher GR.
Bacteremia with otitis media. Pediatrics 1991;
87:48-53.
19. Klein JO. Microbiologic efficacy of antibacterial
drugs for acute otitis media. Pediatr
Infect Dis J 1993;12:973.
20. Thanaviratananich S, Laopaiboon M, Vatanasapt
P. Once or twice daily versus three times
daily amoxicillin with or without clavulanate
for the treatment of acute otitis media.
Cochrane Database Syst Rev 2008;(4):CD00-
4975.
21. Longo G, Barbi E. Amoxicillin dosage. Pediatrics
2002;110:195.
22. Guillemot D, Carbon C, Balkau B, et al.
Low dosage and long treatment duration of
beta-lactam: risk factors for carriage of penicillin-
resistant Streptococcus pneumoniae. JAMA
1998;279:365-70.
23. Fallon RM, Kuti JL, Doern GV, Girotto JE,
Nicolau DP. Pharmacodynamic target attainment
of oral beta-lactams for the empiric treatment
of acute otitis media in children. Paediatr
Drugs 2008;10:329-35.
24. Canafax DM, Yuan Z, Chonmaitree T, et al.
Amoxicillin middle ear fluid penetration and
pharmacokinetics in children with acute otitis
media. Pediatr Infect Dis J 1988;17:149-56.
25. Calvo A, Amores R, Valero E, et al.;
Working Group for the Study of Cefpodoxime
Activity of oral antibiotics against respiratory
tract pathogens in Spain. Rev Esp Quimioter
2003;16:436-43.
Corrispondenza: longog@burlo.trieste.it